Xconomy: New York Biotech – How to make it here

6:15-6:45 PM | The Rgenix Story:

From our beginnings as a small spin-out from Rockefeller University to a world-class team with multiple clinical programs and $40M in Series C funding, our executives tell the story of our Manhattan-based biotechnology company.

Masoud Tavazoie
Masoud Tavazoie – CEO, Rgenix
David Darst
David Darst – COO, Rgenix

Xconomy: New York Biotech – How to make it here | December 18, 2018

Learn More